Hypertension has emerged as a global health and economic crisis, affecting 1.4 billion people and contributing to over 10 million deaths annually. The World Health Organisation’s 2025 Global Hypertension Report warns that uncontrolled high blood pressure could cost low- and middle-income countries an estimated $3.7 trillion by 2025—roughly 2% of their combined GDP.
Nigeria, flagged as a “Nation at Risk,” faces a mounting burden with projections showing its hypertensive population rising to 39.1 million by 2030. Despite recent policy efforts, including the HTN Program and the National Hypertension Control Initiative, systemic barriers such as inadequate data infrastructure, limited access to medication, and low health literacy persist, hindering progress.
This report by TheDigger Intelligence Unit calls for urgent reforms: a nationwide hypertension survey, expanded primary care integration, pharmaceutical regulation, and digital health solutions. Without decisive action, Nigeria risks a public health implosion with far-reaching consequences for its workforce, economy, and future stability.
TheDigger Intelligence Unit
The World Health Organisation’s 2025 Global Hypertension Report reveals a staggering 1.4 billion people living with hypertension worldwide, with only 20% achieving control.
This chronic condition—often dubbed the “silent killer“—is responsible for over 10 million deaths annually. The implications are dire for global health systems, economic productivity, and especially for low- and middle-income countries like Nigeria, where systemic gaps threaten to deepen the crisis.
Global Implications: A Workforce Under Siege
The WHO Global Hypertension report has a far-reaching economic toll, including cardiovascular diseases, such as hypertension, which have been projected to cost low- and middle-income countries $3.7 trillion between 2011 and 2025—roughly 2% of their combined GDP.
Workforce Vulnerability:
Hypertension disproportionately affects the working-age population. In Sub-Saharan Africa, job stress is a major contributor, with prevalence among workers ranging from 14.3% to 45.9%.
Uncontrolled hypertension leads to absenteeism, reduced cognitive function, and premature death, threatening global labour efficiency and economic growth. This underscores the urgent need for effective hypertension management strategies in the workplace.
Nigeria’s Reality Check:
Nigeria has been flagged as a “Nation at Risk” due to the prevalence and accuracy of its data. According to the World Health Organisation and regional studies compiled by the Nigerian Cardiac Society and the Federal Ministry of Health, Nigeria’s hypertensive population is projected to rise from 20.8 million in 2010 to 39.1 million by 2030.
Studies from peer-reviewed publications in the Nigerian Journal of Clinical Practice and African Health Sciences between 2015 and 2022, highlighting regional disparities and methodological inconsistencies, show wildly varying rates—from 9.2% to 70.3%—depending on region, age, and methodology.
Furthermore, there is the issue of data gaps, as Nigeria has not conducted a nationally representative NCD survey since 1992. Current figures are extrapolated from fragmented regional studies, raising concerns about reliability. The Federal Ministry of Health’s 2023 Non-Communicable Disease Policy Review confirmed this assertion. In fact, it calls for updated national data collection.
Government Response and Policy Framework
Nigeria’s Federal Ministry of Health (National Guidelines, 2023) has released a comprehensive guideline for the prevention and management of hypertension, emphasising lifestyle modification, pharmacological therapy, and clinical evaluation.
HTN Program Success:
The Hypertension Treatment in Nigeria (HTN) Program, based on the WHO’s HEARTS package, achieved treatment rates exceeding 90% and control rates above 50% in pilot regions, as authenticated by the HTN Program Evaluation Report (2023), conducted in partnership with the WHO and Resolve to Save Lives.
NHCI Initiative:
Launched in 2020, the National Hypertension Control Initiative (NHCI) aims to decentralise care to primary health centres, improve access to medication, and enhance community engagement.
Systemic Barriers in Nigeria
The most formidable challenge has been access to medication, as frequent stock-outs, high costs, and limited insurance coverage hinder treatment continuity. Additionally, health literacy issues, including low awareness and poor adherence to treatment regimens, remain significant obstacles.
Another significant barrier is the infrastructure deficits. Inadequate data systems, lack of validated BP devices, and insufficiently trained personnel undermine care delivery.
Strategic Recommendations
Nigeria must, as a matter of utmost urgency, conduct a standardised, nationwide hypertension survey to establish accurate prevalence and inform policy.
The Federal Government must scale up the HTN Program by expanding the HEARTS-based model across all states, integrating it into Universal Health Coverage (UHC) reforms.
Workplace Health Promotion must be embedded in a way that introduces cardiovascular risk screening and stress management programs in both the public and private sectors.
It is now more pertinent and imperative than ever before to implement Pharmaceutical Reform: strengthen supply chains, subsidise essential medicines, and enforce price regulation for antihypertensives.
It is highly imperative to initiate digital monitoring and deploy mobile health platforms for patient tracking, adherence reminders, and data collection.
Intelligence Unit Verdict
Hypertension is not merely a health issue—it is a geopolitical and economic threat. Nigeria stands at a critical juncture: with the right reforms, it could become a model for low-income countries. Without them, the nation risks a public health implosion that could destabilise its workforce, economy, and future.
TheDigger Intelligence Unit recommends immediate policy action, cross-sector collaboration, and sustained investment to turn the tide against this silent epidemic. The time to act is now, as the longer we delay, the more lives and economic potential we stand to lose.
Call to Action:
Invest now in hypertension control—or pay later in lives lost and economies drained.